» Articles » PMID: 32765522

The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses

Overview
Journal Front Immunol
Date 2020 Aug 9
PMID 32765522
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Dendritic cells (DCs) are a type of innate immune cells with major relevance in the establishment of an adaptive response, as they are responsible for the activation of lymphocytes. Since their discovery, several reports of their role during infectious diseases have been performed, highlighting their functions and their mechanisms of action. DCs can be categorized into different subsets, and each of these subsets expresses a wide arrange of receptors and molecules that aid them in the clearance of invading pathogens. Interferon (IFN) is a cytokine -a molecule of protein origin- strongly associated with antiviral immune responses. This cytokine is secreted by different cell types and is fundamental in the modulation of both innate and adaptive immune responses against viral infections. Particularly, DCs are one of the most important immune cells that produce IFN, with type I IFNs (α and β) highlighting as the most important, as they are associated with viral clearance. Type I IFN secretion can be induced via different pathways, activated by various components of the virus, such as surface proteins or genetic material. These molecules can trigger the activation of the IFN pathway trough surface receptors, including IFNAR, TLR4, or some intracellular receptors, such as TLR7, TLR9, and TLR3. Here, we discuss various types of dendritic cells found in humans and mice; their contribution to the activation of the antiviral response triggered by the secretion of IFN, through different routes of the induction for this important antiviral cytokine; and as to how DCs are involved in human infections that are considered highly frequent nowadays.

Citing Articles

HIV-1 exploits LBPA-dependent intraepithelial trafficking for productive infection of human intestinal mucosa.

Rader A, Cloherty A, Patel K, Almandawi D, Pajkrt D, Wolthers K PLoS Pathog. 2024; 20(12):e1012714.

PMID: 39729509 PMC: 11676502. DOI: 10.1371/journal.ppat.1012714.


The role of neutrophils in osteosarcoma: insights from laboratory to clinic.

Xia M, Han Y, Sun L, Li D, Zhu C, Li D Front Immunol. 2024; 15:1490712.

PMID: 39582869 PMC: 11582048. DOI: 10.3389/fimmu.2024.1490712.


An Immunohistochemical Study on the Role of CD83+ Dendritic Cells (DCs) in Malignant and Benign Lesions of the Human Cervix.

Ramachandran K Cureus. 2024; 16(10):e71327.

PMID: 39529763 PMC: 11554423. DOI: 10.7759/cureus.71327.


A novel immunomodulating peptide with potential to complement oligodeoxynucleotide-mediated adjuvanticity in vaccination strategies.

Agrez M, Chandler C, Thurecht K, Fletcher N, Liu F, Subramaniam G Sci Rep. 2024; 14(1):26737.

PMID: 39501043 PMC: 11538426. DOI: 10.1038/s41598-024-78150-7.


Monocyte and Macrophage Functions in Oncogenic Viral Infections.

Echevarria-Lima J, Moles R Viruses. 2024; 16(10).

PMID: 39459945 PMC: 11512331. DOI: 10.3390/v16101612.


References
1.
Sozzani S, Vermi W, Del Prete A, Facchetti F . Trafficking properties of plasmacytoid dendritic cells in health and disease. Trends Immunol. 2010; 31(7):270-7. DOI: 10.1016/j.it.2010.05.004. View

2.
Gardner A, Ruffell B . Dendritic Cells and Cancer Immunity. Trends Immunol. 2016; 37(12):855-865. PMC: 5135568. DOI: 10.1016/j.it.2016.09.006. View

3.
. Human Immunodeficiency Virus (HIV). Transfus Med Hemother. 2016; 43(3):203-22. PMC: 4924471. DOI: 10.1159/000445852. View

4.
Del Rio M, Bernhardt G, Rodriguez-Barbosa J, Forster R . Development and functional specialization of CD103+ dendritic cells. Immunol Rev. 2010; 234(1):268-81. DOI: 10.1111/j.0105-2896.2009.00874.x. View

5.
Auffermann-Gretzinger S, Keeffe E, Levy S . Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood. 2001; 97(10):3171-6. DOI: 10.1182/blood.v97.10.3171. View